Indazolyl-substituted pyrroline compounds as kinase inhibitors
US7855203B2 · kind B2 · utility
0Cited by
7References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 13, 2007 |
| Grant date | Dec 21, 2010 |
| Priority date | — |
| Expiry date | Dec 13, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to novel indazolyl-substituted pyrroline compounds of Formula (I):useful as kinase or dual-kinase inhibitors, methods for producing such compounds and methods for treating or ameliorating a kinase or dual-kinase mediated disorder.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.